| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/11/2004 | WO2004056385A3 Modulation of activity of neurotrophins |
| 11/11/2004 | WO2004052919A3 Peptide deformylase inhibitors |
| 11/11/2004 | WO2004048324A3 Chemokine parc suppresses specific cytokine production |
| 11/11/2004 | WO2004042024B1 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF HIF-1 ALPHA |
| 11/11/2004 | WO2004038407A3 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12) |
| 11/11/2004 | WO2004037168A3 Treatment of pancreatitis with amylin |
| 11/11/2004 | WO2004035021A3 Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 11/11/2004 | WO2004031144A3 Use of caspase inhibitors as therapeutic agent against radiation-induced injury |
| 11/11/2004 | WO2004028516A3 Compositions for the inhibition of protein kinase c alpha for treatment of diabetes mellitus and cardiovascular diseases |
| 11/11/2004 | WO2004026907A3 Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals |
| 11/11/2004 | WO2004024872A3 Method for expression of small antiviral rna molecules within a cell |
| 11/11/2004 | WO2004020582A3 Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes |
| 11/11/2004 | WO2004020404A3 Modified transferin-antibody fusion proteins |
| 11/11/2004 | WO2004012681A3 Cancer vaccines containing epitopes of oncofetal antigen |
| 11/11/2004 | WO2004009799A3 Ion channel receptor and uses thereof |
| 11/11/2004 | WO2004009773A3 Methods and compositions for activating or inhibiting vegf-d and vegf-c |
| 11/11/2004 | WO2003104397A3 Antisense modulation of g protein-coupled receptor kinase 6 expression |
| 11/11/2004 | WO2003101394A3 Defensins: use as antiviral agents |
| 11/11/2004 | WO2003087411A8 Method to inhibit cell growth using oligonucleotides |
| 11/11/2004 | WO2003070912A3 RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 11/11/2004 | WO2003070885A3 SHORT INTERFERING NUCLEIC ACID INHIBITION OF STEAROYL-CoA DESATURASE (SCD) GENE |
| 11/11/2004 | WO2003070747A3 Insulin and igf-1 receptor agonists and antagonists |
| 11/11/2004 | WO2003063780A3 Therapeutic composition for treatment of cancer by arginine depletion |
| 11/11/2004 | WO2003060150A8 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling |
| 11/11/2004 | WO2003051285A3 Therapeutic anti-hiv (iv9) compounds |
| 11/11/2004 | WO2003038052A3 Nucleic acid-associated proteins |
| 11/11/2004 | WO2003027239A3 Melanin-concentrating hormone receptor antagonist binding protein |
| 11/11/2004 | WO2003016480A3 Tgf-$g(a) polypeptides, functional fragments and methods of use therefor |
| 11/11/2004 | WO2003012044A3 Hagfish cathelin-associated antimicrobial peptides and genes |
| 11/11/2004 | WO2002096350A3 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 11/11/2004 | WO2002070665A3 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 11/11/2004 | WO2002031117A3 Clasp-2 transmembrane proteins |
| 11/11/2004 | US20040225276 Methods of administering a material into a patient for dermal enhancement |
| 11/11/2004 | US20040225198 Method for treatment of neurodegenerations |
| 11/11/2004 | US20040225120 Process for purifying a compound |
| 11/11/2004 | US20040225118 31 human secreted proteins |
| 11/11/2004 | US20040225113 Keratinocyte derived interferon |
| 11/11/2004 | US20040225112 Genes encoding single chain human leukocyte antigen E (HLA-E) proteins to prevent natural killer cell-mediated cytotoxicity |
| 11/11/2004 | US20040225109 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
| 11/11/2004 | US20040224915 High affinity vascular endothelial growth factor(VEGF) receptor nucleic acid ligands and inhibitors |
| 11/11/2004 | US20040224914 Administering to an individual suffering from the non-cancerous angiogenesis-related disease an amount of a therapeutic formulation effective to reduce the effective amount of clusterin in the individual |
| 11/11/2004 | US20040224911 Transporters and ion channels |
| 11/11/2004 | US20040224909 For inhibiting proliferation of a human tumor cell |
| 11/11/2004 | US20040224908 for treating Gram-positive bacterial infection of skin and soft tissue; remains at therapeutic levels in the bloodstream for 7 days or longer |
| 11/11/2004 | US20040224907 Compositions and methods for reversal of drug resistance |
| 11/11/2004 | US20040224901 for example, (3R)-N-[(1R)-1-[(4-Chlorophenyl)methyl]-2-[3-[cyclohexyl(5-isoxazolylcarbonyl)amino]-1-pyrrolidinyl]-2-oxoethyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide; for treating conditions responsive to the modulation of melanocortin-4 receptors such as obesity, diabetes, and sexual dysfunction |
| 11/11/2004 | US20040224900 Protease inhibitors/immunomodulator drugs; internal ribosome entry site (IRES) |
| 11/11/2004 | US20040224898 inducing lypolysis using a nucleic acid expression vector coding for an insect adipokinetic hormone polypeptide; cyclization and amidation; dietetics; drug screening |
| 11/11/2004 | US20040224897 Antimircobial peptide and methods of use thereof |
| 11/11/2004 | US20040224896 STQ peptides |
| 11/11/2004 | US20040224895 a synergistic mixture of Leutenizing Hormone or Human chorionic gonadotrophin and Follicle stimulating hormone to promote folliculogenesis in anovulatory women; improved fertility |
| 11/11/2004 | US20040224894 Methods and use of motoneuronotrophic factor |
| 11/11/2004 | US20040224893 administering interleukin-1 antagonists; restenosis, atherosclerosis, vascular access dysfunction; anticholesterol, hypotensive agents |
| 11/11/2004 | US20040224892 Oligosaccharides in cosmetic or dermatological compositions for stimulating adhesion of keratinocytes to major proteins of the dermoepidermal junction and restoration of epidermal cohesion |
| 11/11/2004 | US20040224891 Methods for the early diagnosis of ovarian cancer |
| 11/11/2004 | US20040224890 Nasal calcitonin formulations containing chlorobutanol |
| 11/11/2004 | US20040224889 extracellular administration; antisense therapy |
| 11/11/2004 | US20040224888 Use of cardiotrophin in liver diseases |
| 11/11/2004 | US20040224886 Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteins |
| 11/11/2004 | US20040224885 Methods of treating hypertension and compositions for use therein |
| 11/11/2004 | US20040224884 drug screening; increasing bone mass without compromising bone strength or quality by administering an apototic or antiapoptotic agent that binds to the estrogen or androgen receptor without causing hormonal transcriptional activation; bone disorders |
| 11/11/2004 | US20040224883 synergistic administration of a Beta Defensin agent and a beta defensin inducing agent; viricides for chemokine receptor-associated viruses |
| 11/11/2004 | US20040224882 modulating cell growth, cell differentiation, or cell survival; genetic engineering using hedgehog genes and proteins; neurodegenerative diseases; tissue-targeted therapy |
| 11/11/2004 | US20040224881 drug screening for chloride channel blockers; osteoporosis, osteolytic cancer, osteopetrosis, Paget's disease; anticarcinogenic agents |
| 11/11/2004 | US20040224879 Devices and processes for distribution of genetic material to mammalian limb |
| 11/11/2004 | US20040224878 Fertilization of aged oocytes |
| 11/11/2004 | US20040224877 drug delivery method of deglycosylated Vitamin D binding protein (DBP-maf) for angiogenesis inhibition; anticarcinogenic, antitumor agents |
| 11/11/2004 | US20040224876 Combination therapy for the treatment of immunoinflammatory disorders |
| 11/11/2004 | US20040224409 Replication defective plasmid comprising nucleotide sequences coding nerve growth factor for use in the treatment and/or prevention of degenerative neurological diseases; tissue engineering and targeted therapy |
| 11/11/2004 | US20040224406 Nonimmunogenic, biodegradable, growth promoting yarn comprising fibroin fibers for use in hernia repair, tissue wall reconstruction, drug delivery and organ support; biological scaffolds |
| 11/11/2004 | US20040224398 TIMP3 as VEGF inhibitor |
| 11/11/2004 | US20040224393 Modified human granulocyte-colony stimulating factor and process for producing same |
| 11/11/2004 | US20040224392 Novel human 26649, 3259, 57809, 57798, 33358, and 32529 molecules and uses therefor |
| 11/11/2004 | US20040224389 Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same |
| 11/11/2004 | US20040224387 Comprises nucleotide sequences coding fibroblast growth factors for use in prevention and treatment of reproductive, metabolic, kidney, oral, breast, skin and brain disorders; wound healing agents and cosmetic surgery |
| 11/11/2004 | US20040224386 Protein tyrosine kinases |
| 11/11/2004 | US20040224385 Zinc finger binding domains for cnn |
| 11/11/2004 | US20040224384 animal extracts comprising protein hydrozylates used for inducing cartilage formation, prohylaxis of connective tissue disorders and replenishing skin viscoelasticity; wound healing agents |
| 11/11/2004 | US20040224378 Methods for using ADAMTS-12, an integrin and metalloprotease with thrombspondin motifs |
| 11/11/2004 | US20040224368 Type 1 ryanodine receptor-based methods |
| 11/11/2004 | US20040224365 Fluorescent amyloid Abeta peptides and uses thereof |
| 11/11/2004 | US20040224360 Methods for diagnosing renal disorders |
| 11/11/2004 | US20040224357 Nucleotide sequences coding salivary gland microbial polypeptide for use in diagnosis and treatment of digestive, endocrine and immune system disorder |
| 11/11/2004 | US20040224356 Novel human enzymes of the metalloprotease family |
| 11/11/2004 | US20040224355 Using guanylate cyclase gene expression for imaging and treating primary and/or metastatic stomach or esophageal cancer; tissue targeted therapy; genetic vaccines; immunotherapy |
| 11/11/2004 | US20040224335 Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor |
| 11/11/2004 | US20040224323 PAK5 screening methods |
| 11/11/2004 | US20040224316 Using phosphodiesterase 4 inhibitor to treat cognitive training disorders; learning enhancement and enzyme inhibitors |
| 11/11/2004 | US20040224314 G-protein coupled receptors |
| 11/11/2004 | US20040224313 Comprises nucleotide sequences coding cytochrome p450 oxygenase variant for identifying modulator use in diagnosis, prognosis, treatment and prevention of cell proliferative disorders; antitumor agents |
| 11/11/2004 | US20040224039 Compositions and methods for the treatment of diseases and disorder associated with oxidative damage |
| 11/11/2004 | US20040224027 useful for tissue regeneration, particularly when used with orthopedic implants and drug delivery |
| 11/11/2004 | US20040224026 Collagen/polysaccharide bilayer matrix |
| 11/11/2004 | US20040224022 Collagen/polysaccharide bilayer matrix |
| 11/11/2004 | US20040224018 labile agent such as human growth hormone complexed with zinc for example; wet milling suspension of labile agent dispersed in biocompatible polymer and solvent to submicron particles of labile agent; drying to form solid polymer/labile agent matrix; sustained release formulation |
| 11/11/2004 | US20040224016 particles of biologically active, non-aggregated erythropoietin in contact with a salting-out salt dispersed within a biodegradable polymeric matrix; smaller amounts of EPO are used compared to bolus injection regimen because serum EPO levels are maintained closer to therapeutical thresholds. |
| 11/11/2004 | US20040224006 defibrinogenating agent, e.g., ancrod, urokinase, streptokinase, phenobarbital or valproic acid; or a fibrinolytic agent, e.g., advance-generation fibrates, e.g., fenofibrate, a tissue-plasminogen activator that may be recombinant, or a fibrinolytic derivative of recombinant tissue-plasminogen activator |
| 11/11/2004 | US20040224000 Implants for non-radioactive brachytherapy of hormonal-insensitive cancers |
| 11/11/2004 | US20040223997 Antifungal parenteral products |
| 11/11/2004 | US20040223988 Cosmetic composition comprising human serum albumin obtained from transgenic non-human animals |